Program Description & Educational Objectives

In this activity, experts in cardiovascular disease and HIV discuss risk factors for cardiovascular disease in patients with HIV, cardiovascular risk assessment in HIV, and cardiovascular risk associated with HIV therapy.

Statement of Need
This activity addresses specific performance gaps for clinicians who treat patients with HIV, including helping clinicians understand the mechanisms of increased cardiovascular risk in their patients with HIV; how applying current standards for cardiovascular screening may or may not address this risk in patients with HIV; and improving awareness of HIV treatment strategies that may positively affect cardiovascular risk in patients with HIV.

Elements of Competence
This CME activity has been designed to change learner competence and focuses on the American Board of Medical Specialties areas of patient care and medical knowledge.

Upon completion of this activity, participants will be able to:

• Describe the specific mechanisms of cardiovascular disease in patients with HIV, particularly with regard to inflammation, HIV, and aging
• Summarize the current standard of care for screening and managing cardiovascular risk in patients with HIV and the potential impact on HIV-related treatment decisions
• Assess strategies to improve the cardiovascular risk profile in patients with HIV, such as timing and selection of therapy

Target Audience

This activity has been designed to meet the educational needs of HIV physician specialists, HIV nurse specialists, and other clinicians involved in the management of patients with HIV.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME/CNE credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: July 18, 2011 - July 17, 2012
Time to Complete: 30 minutes

Faculty & Disclosure / Conflict of Interest Policy

It is the policy of the University of Wisconsin School of Medicine and Public Health that the faculty, authors, planners, and other persons who may influence content of this CME activity disclose all relevant financial relationships with commercial interests* in order to allow CME staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). For this educational activity all conflicts of interests have been resolved and detailed disclosures are available.
*The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

Course Director and Moderator

David Alain Wohl, MD
Associate Professor
Department of Medicine
Division of Infectious Diseases
University of North Carolina Health Care System
Chapel Hill, North Carolina

David Alain Wohl, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from GlaxoSmithKline and Merck & Co., Inc.
Advisory Board for Gilead and Tibotec Pharmaceuticals; and will not discuss any unlabeled/unapproved drugs/devices.

Interviewee

James H. Stein, MD
Professor
Department of Medicine
Division of Cardiovascular Medicine
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin

James H. Stein, MD, has a financial interest/relationship or affiliation in the form of:
Honoraria from Abbott Laboratories; Eli Lilly and Company; and Takeda Pharmaceuticals North America, Inc. for Data and Safety Monitoring Boards.
Other Financial or Material Support from Wisconsin Alumni Research Foundation in the form of Royalties for patent related to carotid ultrasound and vascular age; and will not discuss any unlabeled/unapproved drugs/devices.

CME Reviewer

James Sosman, MD
Associate Professor of Medicine and Medical Director, HIV Care Program and MATEC-WI
Division of General Medicine and Infectious Diseases
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin

James Sosman, MD, currently has no financial interests/relationships or affiliations in relation to this activity and will not discuss any unlabeled/unapproved drugs/devices.

Content Director

Kathryn B. Charalambous, PhD
PVI, PeerView Institute for Medical Education

Kathryn B. Charalambous, PhD, currently has no financial interests/relationships or affiliations in relation to this activity and will not discuss any unlabeled/unapproved drugs/devices.

Credit Designation

Amy Meyer, MS
Outreach Specialist
Office of Continuing Professional Development
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin

Amy Meyer, MS, currently has no financial interests/relationships or affiliations in relation to this activity and will not discuss any unlabeled/unapproved drugs/devices.

Sponsorship, Credit & Support

Physicians

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Wisconsin School of Medicine and Public Health and PVI, PeerView Institute for Medical Education. The University of Wisconsin School of Medicine and Public Health is accredited by the ACCME to provide continuing medical education for physicians.

The University of Wisconsin School of Medicine and Public Health designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

IAHB is an approved provider of continuing nursing education by the Utah Nurses Association, an accredited Approver by the American Nurses Credentialing Center’s Commission on Accreditation. (UNA = 0.5 CEH's. Provider Code P09-03).

Note: Not all state nursing boards will accept programs less than 1.0 hour in length for credit. Please click here to find out the status of your state.

This CME/CNE activity is jointly sponsored by the University of Wisconsin School of Medicine and Public Health and PVI, PeerView Institute for Medical Education; the activity is also co-provided by the Institute for Advancement of Human Behavior.

This activity is supported by an educational grant from

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the University of Wisconsin School of Medicine and Public Health, the Institute for Advancement of Human Behavior, Bristol-Myers Squibb Company, or PVI, PeerView Institute for Medical Education. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.